(CercleFinance.com) – Dr. Pier Vincenzo Piazza, co-founder and CEO of Aelis Farma, has received an Excellence Award from the European Society for Behavioral Pharmacology (EBPS), the Institute announced on Tuesday. biopharmaceutical company.
Aelis, which develops treatments for brain diseases, indicates that this ‘Distinguished Achievement Award’, awarded for more than 20 years, rewards scientists whose discoveries contribute to advancing research in the field of neurosciences and brain diseases.
During the congress, which took place last week in Mannheim (Germany), Pier Vincenzo Piazza was also named honorary life member of the EBPS.
He had intervened earlier to present the discovery of a new generation of drugs and the work of Aelis Farma, greeting in passing the members of his former Inserm research group.
Aelis is currently working on two drug candidates, one aimed at treating cannabis addiction and the other cognitive deficits related to Down syndrome
The European Society for Behavioral Pharmacology (EBPS) is an international society at the crossroads of pharmacology, experimental psychology, psychiatry and neuroscience.